Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children

NCT03375775 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Rhinitis, Allergic
Conjunctivitis, Allergic
Asthma

Interventions

DRUG: Subcutaneous immunotherapy with ALK Alutard birch or ALK Alutard timothy
OTHER: No immunotherapy, symptomatic treatment

Sponsor

Karolinska Institutet